نتایج جستجو برای: mrd

تعداد نتایج: 1567  

Journal: :CoRR 2016
Javier de la Cruz

In this paper we define and study a family of codes which come close to be MRD codes, so we call them AMRD codes (almost MRD). An AMRD code is a code with rank defect equal to 1. AMRD codes whose duals are AMRD are called dually AMRD. Dually AMRD codes are the closest to the MRD codes given that both they and their dual codes are almost optimal. Necessary and sufficient conditions for the codes...

Journal: :Vision Research 2004
Zhi-Lei Zhang Christopher Cantor Tandra Ghose Clifton M. Schor

Stereo-matching solutions minimize disparity relative to the horopter (minimum-absolute-disparity or MAD), and differences in disparity between adjacent features (minimum-relative-disparity or MRD). When placed in conflict, spatial proximity promotes MRD over MAD solutions. How does temporal proximity of neighboring features affect strength of these spatial interactions? We quantified the inter...

Journal: :Protein science : a publication of the Protein Society 2003
Kristofer Modig Elizabeth Kurian Franklyn G Prendergast Bertil Halle

A fundamental understanding of protein stability and the mechanism of denaturant action must ultimately rest on detailed knowledge about the structure, solvation, and energetics of the denatured state. Here, we use (17)O and (2)H magnetic relaxation dispersion (MRD) to study urea-induced denaturation of intestinal fatty acid-binding protein (I-FABP). MRD is among the few methods that can provid...

2017

Patients diagnosed with chronic lymphocytic leukemia (CLL) do not necessarily have to undergo intensive treatment. The implementation of the therapy depends on patient condition and the form of CLL which is determined using predictive and prognostic factors. Both indolent and aggressive forms of CLL should be monitored. To improve survival and the quality of life it is very important to know ho...

Journal: :Blood 2013
Hong-Hu Zhu Xiao-Hui Zhang Ya-Zhen Qin Dai-Hong Liu Hao Jiang Huan Chen Qian Jiang Lan-Ping Xu Jin Lu Wei Han Li Bao Yu Wang Yu-Hong Chen Jing-Zhi Wang Feng-Rong Wang Yue-Yun Lai Jun-Yue Chai Li-Ru Wang Yan-Rong Liu Kai-Yan Liu Bin Jiang Xiao-Jun Huang

We aimed to improve the outcome of t(8;21) acute myeloid leukemia (AML) in the first complete remission (CR1) by applying risk-directed therapy based on minimal residual disease (MRD) determined by RUNX1/RUNX1T1 transcript levels. Risk-directed therapy included recommending allogeneic hematopoietic stem cell transplantation (allo-HSCT) for high-risk patients and chemotherapy/autologous-HSCT (au...

2012
Eun Sang Yi Soo Hyun Lee Meong Hi Son Ju Youn Kim Eun Joo Cho Su Jin Lim Hee Won Cheuh Keon Hee Yoo Ki Woong Sung Hong Hoe Koo

PURPOSE This study compared outcomes in children with acute leukemia who underwent transplantations with umbilical cord blood (UCB), bone marrow, or peripheral blood stem cells from a human leukocyte antigen (HLA)-matched related donor (MRD) or an unrelated donor (URD). METHODS This retrospective study included consecutive acute leukemia patients who underwent their first allogeneic hematopoi...

2007
Sung Woo Ha Jong Mi Lee Woo Jin Jeung Hee Bae Ahn

PURPOSE To evaluate the clinical effects of conjunctiva-Muller muscle resection through conjunctival incision in anophthalmic patients with mild ptosis. METHODS Conjunctiva-Müller muscle resection was performed by one surgeon in 8 patients (8 eyes) who had received evisceration or enucleation and responded to 10% phenylephrine solution to correct ptosis. The average age of the patients was 35...

Journal: :Blood 2010
Claudio G Brunstein Jonathan A Gutman Daniel J Weisdorf Ann E Woolfrey Todd E Defor Theodore A Gooley Michael R Verneris Frederick R Appelbaum John E Wagner Colleen Delaney

Effectiveness of double umbilical cord blood (dUCB) grafts relative to conventional marrow and mobilized peripheral blood from related and unrelated donors has yet to be established. We studied 536 patients at the Fred Hutchinson Cancer Research Center and University of Minnesota with malignant disease who underwent transplantation with an human leukocyte antigen (HLA)-matched related donor (MR...

Journal: :Blood 2013
Roland B Walter Sarah A Buckley John M Pagel Brent L Wood Barry E Storer Brenda M Sandmaier Min Fang Boglarka Gyurkocza Colleen Delaney Jerald P Radich Elihu H Estey Frederick R Appelbaum

Minimal residual disease (MRD) before myeloablative hematopoietic cell transplantation (HCT) is associated with adverse outcome in acute myeloid leukemia (AML) in first complete remission (CR1). To compare this association with that for patients in second complete remission (CR2) and to examine the quantitative impact of MRD, we studied 253 consecutive patients receiving myeloablative HCT for A...

Journal: :Oncotarget 2015
Houria Debarri Delphine Lebon Christophe Roumier Meyling Cheok Alice Marceau-Renaut Olivier Nibourel Sandrine Geffroy Nathalie Helevaut Philippe Rousselot Bérengère Gruson Claude Gardin Marie-Lorraine Chretien Shéhérazade Sebda Martin Figeac Céline Berthon Bruno Quesnel Nicolas Boissel Sylvie Castaigne Hervé Dombret Aline Renneville Claude Preudhomme

Acute myeloid leukemia (AML) is a heterogeneous disease. Even within the same NPM1-mutated genetic subgroup, some patients harbor additional mutations in FLT3, IDH1/2, DNMT3A or TET2. Recent studies have shown the prognostic significance of minimal residual disease (MRD) in AML but it remains to be determined which molecular markers are the most suitable for MRD monitoring. Recent advances in n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید